» Articles » PMID: 22639107

Thymic Neoplasms: a Clinical Update

Overview
Journal Curr Oncol Rep
Publisher Current Science
Specialty Oncology
Date 2012 May 29
PMID 22639107
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Thymoma is a unique neoplasm of the anterior mediastinum that is frequently associated with indolent growth and a variety of paraneoplastic syndromes. One third of cases are detected during the evaluation of myasthenia gravis. Classification systems of thymoma have limited ability in accurately predicting prognosis and course of disease. Thus, staging is the only way to predict clinical behavior. Encapsulated tumors that are surgically resected carry the best prognosis. Adjuvant radiotherapy is recommended for incompletely excised and most invasive thymomas. Chemotherapy in anthracycline-based chemotherapy remains the most effective chemotherapy for neoadjuvant, adjuvant or palliative treatment.

Citing Articles

Are the minimally invasive techniques the new gold standard in thymus surgery for myasthenia gravis? Experience of a reference single-site in VATS thymectomy.

Trujillo Reyes J, Martinez Tellez E, Belda Sanchis J, Planas Canovas G, Libreros Nino A, Guarino M Front Neurol. 2024; 15:1309173.

PMID: 38361645 PMC: 10867208. DOI: 10.3389/fneur.2024.1309173.


Tc MIBI THYMIC SCINTIGRAPHY IN DIAGNOSIS AND THERAPEUTIC DECISION MAKING: WHAT IS BEHIND THE IMAGE?.

Stefanescu C, Ionescu L, Danila R, Butcovan D, Tibu R, Bilha S Acta Endocrinol (Buchar). 2019; 12(3):249-256.

PMID: 31149097 PMC: 6535270. DOI: 10.4183/aeb.2016.249.


Possible roles of genetic variations in chemotherapy related cardiotoxicity in pediatric acute lymphoblastic leukemia and osteosarcoma.

Sagi J, Egyed B, Kelemen A, Kutszegi N, Hegyi M, Gezsi A BMC Cancer. 2018; 18(1):704.

PMID: 29970035 PMC: 6029426. DOI: 10.1186/s12885-018-4629-6.


Malignant thymoma with metastasis associated with paraneoplastic myasthenia gravis.

Jazi H, Harmon D, Tran T, Denham C Proc (Bayl Univ Med Cent). 2017; 30(3):330-332.

PMID: 28670075 PMC: 5468033. DOI: 10.1080/08998280.2017.11929636.


Development of combined thymic carcinoma and thymoma in an extrathymic lesion during long follow-up for recurrent thymoma.

Ohue Y, Matsuoka S, Kumeda H, Agatsuma H, Hyougotani A, Toishi M Mol Clin Oncol. 2016; 4(2):139-142.

PMID: 26893849 PMC: 4734238. DOI: 10.3892/mco.2015.708.


References
1.
Souadjian J, Enriquez P, SILVERSTEIN M, PEPIN J . The spectrum of diseases associated with thymoma. Coincidence or syndrome?. Arch Intern Med. 1974; 134(2):374-9. View

2.
Loehrer Sr P, Wang W, Johnson D, Aisner S, Ettinger D . Octreotide alone or with prednisone in patients with advanced thymoma and thymic carcinoma: an Eastern Cooperative Oncology Group Phase II Trial. J Clin Oncol. 2004; 22(2):293-9. DOI: 10.1200/JCO.2004.02.047. View

3.
Liu R, Yeh S, Huang M, Wang L, Chu L, Chang C . Use of fluorine-18 fluorodeoxyglucose positron emission tomography in the detection of thymoma: a preliminary report. Eur J Nucl Med. 1995; 22(12):1402-7. DOI: 10.1007/BF01791148. View

4.
Blossom G, Ernstoff R, Howells G, Bendick P, Glover J . Thymectomy for myasthenia gravis. Arch Surg. 1993; 128(8):855-62. DOI: 10.1001/archsurg.1993.01420200029005. View

5.
Gerein A, Srivastava S, Burgess J . Thymoma: a ten year review. Am J Surg. 1978; 136(1):49-53. DOI: 10.1016/0002-9610(78)90199-x. View